Identification of KIAA1024 as a novel cell surface protein involved in angiogenesis by Park, Michael
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2016
Identification of KIAA1024 as a
novel cell surface protein involved
in angiogenesis
https://hdl.handle.net/2144/17003
Boston University
BOSTON UNIVERSITY 
 
SCHOOL OF MEDICINE 
 
 
 
 
Thesis 
 
 
 
 
IDENTIFICATION OF KIAA1024 AS A NOVEL CELL SURFACE PROTEIN 
 
 INVOLVED IN ANGIOGENESIS 
 
 
 
by 
 
 
 
MICHAEL PARK 
 
B.A., New York University, 2013 
 
 
 
 
 
Submitted in partial fulfillment of the 
 
requirements for the degree of 
 
Master of Science 
 
2016 
	 	 	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2016 by 
 MICHAEL PARK 
 All rights reserved  
	 	 	
Approved by 
 
 
 
 
First Reader   
 Nader Rahimi, Ph.D. 
 Associate Professor of Pathology & Laboratory of Medicine 
 
 
Second Reader   
 Vipul Chitalia, M.D., Ph.D. 
 Assistant Professor, Boston University School of Medicine 
 
 
 
		 iv 
ACKNOWLEDGMENTS 
 
First and foremost, I thank Dr. Nader Rahimi for his endless amount of patience 
and knowledge which helped me gain insights on how to become not only a 
better scientist, but also a better person. As a mentor and a scientist, he is second 
to none, and I truly appreciate the opportunity to work in his lab.  I would also 
like to thank everyone in the Rahimi lab for their help and for creating such a 
friendly environment: Rosana, Zou, Philip, Kevin, Mehrdad, Walt, and Brad. 
Thank you Dr. Chitalia for reading my thesis and input. Finally, I would like to 
thank my father, mother, my brother Alex, and Christine for all of their love and 
support.  
This work was supported in part through grants from the NIH (R21CA191970 
and R21CA193958 to N.R.). 
 
  
		 v 
IDENTIFICATION OF KIAA1024 AS A NOVEL CELL SURFACE PROTEIN 
INVOLVED IN ANGIOGENESIS 
MICHAEL PARK 
ABSTRACT 
 Angiogenesis is the formation of new blood vessels from preexisting 
vessels, which involves endothelial cell migration, differentiation and 
proliferation. Angiogenesis is mediated by a variety of cell surface receptors 
including growth factor receptors, cell adhesion molecules and others with pro- 
and anti-angiogenic functions. The primary goal of this study was to determine 
the expression of KIAA1024 in endothelial cells and elucidate its functional 
importance in endothelial cells. Our study, for the first time, demonstrated that 
KIAA1024 is expressed in human endothelial and various cancer cell lines. We 
further demonstrated that ectopic expression of KIAA1024 in porcine aortic 
endothelial (PAE) cells inhibits cell migration in both Boyden chamber and cell 
scratch assays. Additionally, overexpression of KIAA1024 in PAE cells 
significantly altered actin stress fiber formation and reduced capillary tube 
formation. Interestingly, unlike its inhibitory effect on capillary tube formation, 
overexpression of KIAA1024 in PAE cells increased cell migration, cell survival 
and inhibited phosphorylation of pro-apoptosis p38MAPK. Taken together, the 
		 vi 
data presented in this study identifies KIAA1024 as a novel cell surface receptor 
expressed in endothelial cells and regulates angiogenic properties of endothelial 
cells.  
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INTRODUCTION 
Angiogenesis is the formation of new blood vessels from preexisting 
vessels. This process is different from vasculogenesis, which is de novo formation 
of blood vessels from vascular progenitor cells and occurs during embryonic 
development.  Angiogenesis can be divided into two types: physiological and 
pathological angiogenesis. Physiological angiogenesis is important for wound 
healing, organ regeneration and placenta formation in vasculogenesis (Hoeben et 
al., 2004). For adults, it does not occur normally except in a few conditions, such 
as the female reproductive cycle (Bischoff 1996). While it can be a helpful 
response, dysregulated angiogenesis can also be quite harmful. Pathological 
angiogenesis can cause certain conditions such as the neovascularization of solid 
tumors and blood vessel growth in diabetic retinopathy (Bischoff 1996). 
Angiogenesis is tightly monitored and affected by many signals, some 
stimulatory and some inhibitory.  
 There are a variety of stimulatory and inhibitory signals in angiogenesis 
that are tightly controlled (Hoeben et al., 2004). Vascular endothelial growth 
factor (VEGF) is one of the most important stimulatory and well-characterized 
angiogenic signals. Currently, the VEGF family contains seven members: VEGF-
A, VEGF-B, VEGF-C, VEGF-D, VEGF-E, VEGF-F, and PIGF (Hoeben et al., 2004). 
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Each one is a specific mitogen for endothelial cells that binds to tyrosine kinase 
receptors leading to new vessel formation, endothelial cell migration and 
proliferation (Hoeben et al., 2004). The three VEGF tyrosine kinase receptors 
currently identified are VEGFR-1, VEGFR-2, and VEGFR-3. VEGFR-2 is the most 
important receptor in VEGF-induced mitogenesis and permeability while the 
role of VEGFR-1 is not as clear (Hoeben et. al., 2004). When VEGF binds to 
VEGFR-2, the receptor is dimerized, causing it to activate and release platelet-
activating factor (PAF) (Hoeben et al., 2004).  PAF is involved in many different 
roles such as inflammatory cell rolling and adhesion, promoting the expression 
of angiogenic factors and potentiating the migration of endothelial cells (Hoeben 
et al., 2004). 
 Another important angiogenic growth factor is fibroblast growth factor 
(FGF). There are currently at least 20 factors in the FGF family with FGF-1 and 
FGF-2 being the most renown (Cross et al., 2001). These two lack a cytoplasmic 
sequence for extracellular export which has made their role in angiogenesis 
questionable. It appears that FGFs have a high affinity to bind to heparin sulfate 
proteoglycans (HSPGs), found on the surface of most cells within the 
extracellular matrix (Cross et al., 2001). FGFs bind to one of four fibroblast 
growth factor receptors: FGFR-1, FGFR-2, FGFR-3 and FGFR-4 (Cross et al., 
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2001).  Once FGF binds to an FGFR, with HSPG serving as a co-receptor, FGFR 
dimerizes and autophosphorylates. This directly activates intracellular signaling 
proteins such as Crk and PLCγ while others are indirectly activated such as Shc 
and FRS-2 (Cross et al., 2001). Some other proteins activated by FGFR-1 include 
Src, Shb, p38 MAPK and PI3K (Cross et al., 2001). FGF, along with VEGF, 
stimulate survival, proliferation, migration and differentiation of primary and 
stable endothelial cells (Cross et al., 2001). 
There are two types of angiogenesis: sprouting angiogenesis and 
intussusceptive or non-sprouting angiogenesis. In intussusceptive angiogenesis, 
interstitial tissue invades an existing vessel and splits it into two. This form of 
angiogenesis was first observed in neonatal rats (Djonov et al., 2003). There are 
four phases involved in this process. First, opposing capillary walls extend until 
contact is made (Burri et al., 2004). Next, the inter-endothelial cell junctions are 
reorganized and the vessel bilayer becomes perforated (Djonov et al., 2003). In 
stage three, an interstitial pillar core is formed followed by the invasion of 
pericytes and myofibroblasts that place collagen fibers into the core so that the 
vessel lumen has an extracellular matrix for growth (Djonov et al., 2003). In the 
final phase, the core’s girth increases without changing anything to its basic 
structure (Djonov et al., 2003). Intussusception is important because it allows an 
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increase in the number of capillaries without increasing the number of 
endothelial cells.  
 The second type of angiogenesis is sprouting angiogenesis.  Unlike 
intussusception, sprouting angiogenesis produces completely new blood vessels 
rather than splitting existing ones. However, like intussusception, there are 
distinct phases. First, a distinct site must be chosen on the original vessel. Next, 
the endothelial cell receptors are activated by angiogenic growth factors. 
Proteases are released from the activated endothelial cells which increase the 
permeability of the basement membrane. Tip cells shoot out filopodia and 
migrate towards the growth factor source (Gerhardt, 2004). The cells following 
the tip cells become stalk cells and elongate, sprout and proliferate. Tip cells 
eventually fuse together and create a lumen. The endothelial cells proliferate into 
the neighboring matrix and form sprouts to connect to other neighboring vessels. 
A study has shown that regulation of tip cells after VEGF stimulation is 
determined by the signaling of DLL4/NOTCH1 (Gerhardt, 2004). The tip cell 
count of mice in vivo was increased after loss of DLL4/NOTCH signaling 
(Gerhardt, 2004). On the other hand, mice with decreased DLL4/NOTCH activity 
showed excessive sprouting and fusion as well as increased filopodia protrusions 
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and tip cell numbers (Gerhardt, 2004). Therefore, in regions exposed to VEGF, 
DLL4/NOTCH signaling acts to limit tip cell formation.  
 Cell adhesion molecules (CAMs) also are extremely important for 
angiogenesis. There are four distinct families of CAMs: selectins, cadherins, 
integrins and immunoglobulin superfamily (IGSF). They are located on the cell 
surface and they bind with other cells or with the extracellular matrix through 
cell adhesion (Juliano, 2002). These CAMs strongly influence various signaling 
events such as mitogenesis, survival and differentiation (Juliano, 2002). They do 
this by forming organized structures or scaffolds, which allow signaling 
pathways to more effectively relay information (Juliano, 2002). 
Cadherins are also important for angiogenesis.  They are comprised of 
transmembrane proteins that share an extracellular domain. A study showed 
that capillary tube formation between either a collagen gel or fibrin was inhibited 
by vascular endothelial cadherin (VE-cadherin) (Bach et al., 1998). Specifically, 
the study mentioned that at areas of intercellular contact, VE-cadherin was 
localized where it tried to keep the structural integrity of growing blood vessels 
(Bach et al., 1998). The relationship between CAMs and growth factors is 
complex. A notable pathway promoted by VEGF is the PI3K/Akt pathway which 
helps promote endothelial cell survival (Gerber et al., 1998). VE-cadherin uses β-
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catenin as a mediator, and when VE-cadherin is inactivated, endothelial cells no 
longer receive the survival benefits given by VEGF (Carmeliet et al., 1999). 
 Integrins are glycoproteins that act as receptors for extracellular matrix 
proteins. They are heterodimers and consist of an α unit and β unit. On the 
endothelial cell surface, the αv integrin is overexpressed in particular to facilitate 
growth and survival of newly forming vessels during angiogenesis (Weis and 
Cheresh, 2011). When the αv integrin is blocked by a monoclonal antibody 
(MAb) in chick chorioallantoic membrane, angiogenesis is suppressed (Brooks et. 
al 1994). This shows that if the αv integrin is blocked, it appears to have an anti-
angiogenic effect (Weis and Cheresh, 2011). Although the extracellular domain of 
the integrin controls ligand binding specificity, it is the intracellular region that 
regulates specific kinases and signaling molecules. This facilitates the signaling 
pathways responsible for endothelial cell migration, invasion, proliferation and 
survival (Weis and Cheresh, 2011). 
 Immunoglobulin superfamily cell adhesion molecules (IgCAMs) are also 
important players in angiogenic endothelial cell-cell adhesion and migration 
(Rahimi et al., 2012). The structures of IgCAMs consist of an extracellular 
immunoglobulin domain and a single transmembrane domain (Aplin et al., 
1998). On some leukocytes, endothelial cells and platelets, there is a homotypic 
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IgCAM receptor called PECAM-1 (Juliano, 2002). PECAM-1 has been proven to 
induce signal transduction since the αvβ integrin is activated after the protein is 
ligated (Juliano, 2002). Also, two immunoreceptor tyrosine-based inhibitory 
motifs (ITIMs) are present in the cytoplasmic domain of PECAM-1. SHP-1 and 
SHP-2 tyrosine phosphatases have been show to bind to PECAM-1 (Gratzinger et 
al., 2003). The signals provided by cell surface receptors that recruit tyrosine 
kinases (Juliano, 2002) are counterbalanced by the negative signals from the 
dephosphorylated kinases (Juliano, 2002). Not only are specific CAMs important, 
but also how they interact with each other is worth studying. 
 The overall goal of this project was to investigate expression and function 
of KIAA1024 in endothelial cells. KIAA1024 is a 916 amino acid protein with a 
predicted molecular weight of 100 kDa that is located on human chromosome 15. 
KIAA1024 is one of over 2000 identified human genes from the Human 
Unidentified Gene-Encoding protein database (HUGE database) (Kikuno et al., 
2004). However, beyond its nucleotide identity, nothing is known about 
KIAA1024 expression and function. KIAA1024 was recently identified in our 
laboratory with several other cell surface proteins such as IGPR-1 (Rahimi et al., 
2012) and TMIGD1 (Arafa et al., 2005). 
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 The overarching objectives of this project were: (A) Determine expression 
of KIAA1024 expression in endothelial and cancer cell lines. (B) Investigate the 
biological importance of KIAA1024 in endothelial cells. (C) Determine putative 
signaling pathways involved in the KIAA1024-mediated cellular responses in 
endothelial cells. (D) Identify potential KIAA1024 interacting cell surface binding 
receptors in endothelial cells. The following experiments were performed to 
achieve the objectives of this study. 
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METHODS  
 
Antibodies and Reagents 
The antibody rabbit polyclonal anti-KIAA1024 was developed in house 
that specifically recognizes KIAA1024. Rabbit polyclonal anti-PLCγ1, mouse 
polyclonal anti-α-tubulin and anti-p388 MAPK were purchased from Santa Cruz 
Biotechnology Inc. (Santa Cruz, CA). Rabbit polyclonal anti-NOTCH2, rabbit 
polyclonal anti-phospho-p44/42 MAPK, rabbit polyclonal anti-p44/42 MAPK and 
rabbit polyclonal anti-phospho-p38 MAPK were purchased from Cell Signaling 
Technology (Beverly, MA). CellTiter 96 Non-Radioactive Cell Proliferation Assay 
was purchased from Promega (Madison, WI). 
Cell Culture 
Porcine aortic endothelial (PAE) cells were grown in Dulbecco’s modified 
essential medium (DMEM) that contained 50 units/ml of penicillin and 
streptomycin antibiotic solution and 10% fetal bovine serum (FBS). All cells were 
placed in a 5% CO2 humidified chamber and incubated at 37°C. PAE cells 
expressing empty vector (pLNCX2) or KIAA1024 were generated using a 
pLNCX2 vector as described (Rahimi et al., 2000). 
Western Blot Analysis 
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Cells were washed three times with H/S buffer [25mM Hepes [pH 
7.4]/150mM NaCl] and then lysed in EB lysis buffer [10mM Tris-HCl/10% 
Glycerol/5 mM EDTA (pH 7.4)/50 mM NaCl/50 mM NaF/1% Triton X-100/1 mM 
phenylmethylsulfonyl fluoride/2 mM sodium orthovanadate/aprotinin (20 
mg/ml)]. For some experiments, cells were serum-starved for 24 hours prior to 
lysis. The cell lysates were collected and then mixed with 5X Sample Buffer 
[bromophenol blue (0.25%)/dithiothreeitol (DTT)(0.5M)/glycerol (50%), sodium 
dodecyl sulfate (SDS)(10%)/Tris – Cl (0.25M, pH 6.8)] and heat shocked at 95°C 
for five minutes. Cell lysates are then resolved by SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) and transferred on to polyvinylidene difluoride 
(PVDF) membranes and immunoblotted with antibodies targeting the proteins of 
interest. For some experiments, membranes were stripped using stripping buffer 
[1M Tris-HCl pH 6.8 / 20% SDS / β-Mercaptoethanol (700µl / 100 ml)] and then 
re-probed with another antibody. Antibodies were diluted in 1X TBS solution of 
10% bovine serum albumin. The dilution for the anti-KIAA1024 antibody was 
1:5000, 1:750 for anti-PLCγ antibody, 1:2000 for anti-α-tubulin antibody, 1:1000 
for anti-p44/42 MAPK, anti-phospho-p44/42 MAPK, and anti-phospho-p38 
MAPK antibodies and 1:500 for anti-p38 MAPK antibody. Secondary antibodies 
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were used at 1:12,000 for both anti-rabbit-IgG HRP-linked antibody and anti-
mouse-IgG HRP-linked antibody. 
Immunoprecipitation 
Cell lysates were first pre cleared with protein A-Sepharose by adding 
35µL of protein A-Sepharose, incubated at 4°C in a rotating incubator for one 
hour, and then centrifuged at 5000rpm for five minutes. 5µL of the primary 
antibody was added to all of the samples and then incubated at 4°C in a rotating 
incubator for two hours. 35µL of protein A-Sepharose was added again to each 
sample and then incubated at 4°C in a rotating incubator for one hour. The beads 
were washed three times in lysis buffer as previously described. 2x sample buffer 
as previously described was added and then the samples were boiled at 95°C for 
seven minutes. 
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay 
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
assay kit (Promega) was used to measure endothelial cell survival. PAE cells 
(2x104) expressing empty vector and KIAA1024 were seeded into 24-well tissue 
culture plates and serum starved for 0,2,4 and 6 days. The cells were incubated 
with an MTT yellow tetrazole dye for two hours at 37°C with a concentration of 
10µL/400µL of media. “Stop solution” was added to solubilize the insoluble 
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purple formazan that was produced during incubation, and the cells were 
incubated for one hour at 37°C. After incubation, 200µL of solubilized solution 
from the wells was transferred to a 96-well plate with four wells per group and 
underwent spectrophotometric analysis at 570nm. 
Mass Spectrometry Analysis 
KIAA1024 was immunoprecipitated as previously described using anti-
KIAA1024 antibody from PAE cells expressing ectopic KIAA1024. The gel 
section of interest was cut and prepared for Mass Spectrometry Analysis. Gel 
samples were further cut into smaller pieces and then placed into Eppendorf 
tubes. First, the gel section was de-stained in a solution of 50mM ammonium 
bicarbonate and acetonitrile. 300µL of this de-staining solution was added to 
each gel sample and placed in an incubator set at 30°C for 30 minutes. Next, 
300µL of 10mM dithiothreitol in 50mM ammonium bicarbonate was added to 
each sample and placed in an incubator set at 60°C for 30 minutes. The aqueous 
solution was removed and then 100µL of acetonitrile was added to each tube. 
Samples were placed in a Thermomixer for five minutes. The acetonitrile was 
removed and then 300µL of 50mM iodoacetamide in 50mM ammonium 
bicarbonate was added to each sample and then incubated for 1 hour in the dark. 
After 1 hour, three rinse cycles were performed: 5 min 100µL acetonitrile and 5 
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min 100µL double distilled H2O. The samples were sonicated during each step of 
the wash cycle. After the last wash, the samples were washed one more time in a 
solution of double distilled H2O and acetonitrile and sonicated for 5 minutes. 
The solution was removed and then the samples were placed in the SpeedVac to 
dry for 3-4 hours. After drying, the samples were then subjected to trypsin 
proteolytic digestion on a ProGest device (Genomic Solutions). The samples were 
analyzed by nano-LC-MS/MS on a Thermo Fisher LTQ Orbitrap XL and then 
further analyzed using the program Scaffold (Courtesy of Kevin Chandler). 
Endothelial cell capillary tube formation and wounding assay 
PAE cells overexpressing KIAA1024 and PAE cells expressing empty 
vector were seeded on matrigel with endothelial cell growth medium (Clonetics, 
San Diego, CA). After 24 hours, capillary tube formation was viewed under 
microscope and photographed as described (Meyer et al., 2008). Quantification of 
capillary tube formation was established by using ImageJ (National Institutes of 
Health, Bethesda, MD). The wounding assay was performed by using the tip of a 
5mL tissue culture pipette to create multiple “wounds” or scratches across the 
cell monolayer. After 10 hours, the cell culture plates were viewed under 
microscope. Images were captured and documented. 
Boyden Chamber migration Assay 
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Transwell permeable supports with 8-µm pore size polycarbonate filters 
purchased from Corning Incorporated (Kennebunk, ME). 500µL of DMEM was 
added in the bottom of a 24-well plate. The Transwell support was added to the 
media filled chamber. 2x103 cells of PAE EV were added to two supports and 
2x103 cells of PAE KIAA1024 were added to another two supports. These 
supports were then placed in the well containing the DMEM media. Chambers 
were incubated at 37°C for 15 hours. After incubation, the membranes were cut 
from the chambers and fixed and stained with Diff-Quik (Dade Internation, 
Miami, FL). The membranes were washed with water and then mounted on glass 
slides and viewed under microscope.  
Immunohistochemistry (Courtesy of Philip Bondzie) 
Human tissue samples were provided by Boston University Department of 
Pathology (Boston, MA). After formalin fixation and paraffin embedding (FFPE), 
5µm sections were cut and mounted on slides. Sections were deparaffinized, 
hydrated, and rinsed in distilled water (dH2O), then subject to heat-induced 
antigen retrieval with 1X citrate buffer [10 mM citric acid and 0.05% Tween-20, 
pH 6.0] for 20 minutes at 98°C. Slides were then rinsed in dH2O and blocked 
with 200-500µL 1X blocking buffer [made from 10X Power Block Universal 
Blocking Reagent] (cat # HK085-5K; BioGenex, Fremont, CA) for 30 minutes at 
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room temperature in a humidified chamber. After removal of this 1X blocking 
buffer, rabbit anti-KIAA1024 antibody was diluted in 1X blocking buffer and 
added to each section for 60 minutes. The primary antibody solution was 
removed from the section and washed for five minutes three times in Western 
Rinse. Then, One-Step Polymer-HRP (cat # HK595-50K; BioGenex) was added to 
the sections and incubated for 30 minutes in a humidified chamber. Next, 
Polymer-HRP was removed from the sections and washed three times in 
Western Rinse. 3% hydrogen peroxide solution was added to each sample for 15 
minutes after the third wash and then washed three more times in Western 
Rinse. Western Rinse was removed from each sample and then 100L DAB 
solution consisting of 20µL DAB Chromogen (cat # HK124-05K; BioGenex) and 1 
mL Stable DAB Buffer (cat # HK520-50K; BioGenex) was added to each tissue 
sample. After a three minute incubation, samples were immediately immersed in 
dH2O and counterstained in Mayer’s hematoxylin for 10 seconds. After the 
sections were dehydrated and mounted, microscopy images were taken at 40X. 
Immunofluorescent Microscopy (Courtesy of Philip Bondzie) 
PAE cells overexpressing KIAA1024 and PAE cells expressing empty 
vector were fixed with 4% paraformaldehyde for 30 minutes. Before fixing, the 
slides were washed with Tris-Buffered Saline (TBS). After being blocked with 1% 
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bovine serum albumin (BSA) in TBS buffer, the slides were incubated with anti-
KIAA1024 antibody. The slides were then incubated with fluorescein 
isothiocyanate (FITC)-conjugated secondary antibody in 1% BSA with TPS for 60 
minutes. Secondary-antibody was removed from the slides and then washed 
with TBS. The slides were then mounted with DAPI (4’,6-diamidino-2-
phenylindole). Images were taken with Nikon Reconvolution Wide-Field 
Epitfluorescence System (Image core facility, Boston University).  
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RESULTS 
 
KIAA1024 is expressed in a variety of cell types and in human tissue 
To demonstrate the ectopic expression of KIAA, a variety of cell types 
were subjected to Western blot analysis. Human colon cancer cells HCT116, 
DLD-1, HT-29 and HCT-15 and human kidney colon cancer cells TK-10 and 786-0 
were shown to express KIAA with an apparent molecular weight of 103 kDa 
(Figure 1A). Immunohistochemical staining showed that KIAA1024 is expressed 
in blood vessels and in epithelial cells of the colon (Figure 1B). The staining 
shows that in humans, KIAA1024 is expressed in both endothelial cells and in 
epithelial cells.  
KIAA1024 inhibits capillary tube formation 
Adhesion molecules have been shown to regulate the formation of capillary 
tubes of endothelial cells (Rahimi et al., 2012). Since KIAA1024 is expressed by 
endothelial cells, there is a possibility that it plays a role in angiogenesis. PAE 
cells overexpressing KIAA1024 and empty vector were subjected to a matrigel-
based angiogenesis assay. The analysis showed that PAE cells overexpressing 
KIAA1024 cells had decreased capillary tube formation (Figure 2A). Capillary 
tube formation of the two groups of PAE cells was quantified and shown (Figure 
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2B). The capillary tubes formed by PAE cells expressing empty vector were 
significantly longer than PAE cells expressing KIAA1024. 
 
 
Figure 1: KIAA1024 is expressed in various cell types and human tissue. (A) 
Expression of KIAA1024 in various cell types and protein loading control. (B) 
The human tissues are stained for KIAA1024. The red arrows indicate KIAA1024. 
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Figure 2: KIAA1024 inhibits capillary tube formation. (A) PAE cells expressing 
KIAA1024 or empty vector were subjected to matrigel assay and pictures were 
taken after 24 h. (B) Quantitative analysis of the average length of the branches 
between EV/PAE and KIAA/PAE. 
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KIAA1024 promotes cell migration 
To demonstrate the ectopic expression of KIAA1024, whole cell lysates from PAE 
cells that have been transduced to express KIAA1024 (KIAA/PAE) or empty 
vector (EV/PAE) were lysed and then underwent Western blot analysis using an 
anti-KIAA1024 antibody (Figure 5A). PAE cells expressing KIAA1024 and EV 
were subjected to a wounding assay in order to determine the KIAA1024’s role in 
cell migration. After 10 hours, the KIAA/PAE cells showed much more migration 
towards the wound site compared to the EV/PAE cells (Figures 3A, 3B, 3C, 3D).  
Further evidence of KIAA1024’s role in cell migration was demonstrated using 
the Transwell migration assay. As shown in the figure, many more KIAA/PAE 
cells (Figure 4A) passed through the membrane compared to EV/PAE cells 
(Figure 4B). Figure 4C shows that more than double the amount of KIAA/PAE 
cells migrated as opposed to EV/PAE. Taken together, the data suggests that 
KIAA1024 plays a role in cell migration. 
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Figure 3: KIAA1024 promotes cell migration as shown by wounding assay. (A, 
B, C, D) PAE cells expressing KIAA1024 vs. empty vector were subjected to 
wounding assay. (C, D) were taken 10 h after the wound was created.  
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Figure 4: KIAA1024 promotes cell migration as shown by Boyden Chamber 
assay. (A, B) PAE cells expressing KIAA1024 vs. empty vector were subjected to 
Boyden Chamber assay. (C) Quantification of cell migration. Error bars indicate 
range. 
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KIAA1024 promotes endothelial cell survival 
The current role of KIAA1024 in endothelial cell survival is not known. Since it 
seems to be up-regulated in cancer cell lines, it seemed possible that KIAA1024 
plays a role in endothelial cell survival. To determine whether or not ectopic 
expression of KIAA1024 in endothelial cells promotes survival, EV/PAE and 
KIAA/PAE cells were subjugated to an MTT viability assay (Figure 5B). While 
the number of viable cells varied throughout the days, by day six, PAE cells 
overexpressing KIAA1024 had approximately a 100% increase in cell survival 
when compared to PAE cells expressing empty vector. 
KIAA1024 expression PAE cells alters actin stress fiber formation 
Actin stress fiber formation plays a critical role in endothelial cell migration and 
the formation of capillary tubes. Since over-expression of KIAA1024 in PAE cells 
affected endothelial cell migration and angiogenesis, we decided to examine the 
effect of KIAA1024 in actin stress fiber formation. The results showed that PAE 
cells overexpressing KIAA1024 had a different actin filament assembly as 
compared to PAE cells expressing empty vector. KIAA/PAE formed stress fibers 
that were long and continuous, spanning across multiple cells (Figure 6B). 
However, in EV/PAE cells, the stress fibers were short and discontinuous (Figure 
6A. The data suggest that KIAA1024 regulates actin stress fiber remodeling. 
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Figure 5: KIAA1024 promotes endothelial cell survival. (A) Expression of 
KIAA1024 in PAE cells expressing empty vector vs. PAE cells overexpressing 
KIAA1024 and protein loading control. (B) Cell survival was measured by MTT 
assay. Error bars indicate range. 
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Figure 6: KIAA1024 affects actin stress fiber formation. (A, B) PAE cells 
expressing empty vector or KIAA1024 were fixed and subjected to 
immunofluorescence staining using anti-KIAA1024 antibody. KIAA/PAE has 
long, continuous actin stress fibers that cross multiple cells while EV/PAE has 
short, discontinuous actin stress fibers. 
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KIAA1024 does not appear to regulate phosphorylation of p44/42 MAPK in 
endothelial cells 
PAE cells that expressed empty vector and KIAA1024 as well as PAE cells that 
have been serum starved for 24 hours were blotted using anti-phospho-p44/42 
MAPK and anti-p44/42 MAPK antibodies (Figure 7). There was no noticeable 
difference between the groups. 
KIAA1024 regulates phosphorylation of p38 MAPK in endothelial cells 
PAE cells expressing empty vector and KIAA1024 and serum starved PAE cells 
expressing empty vector and KIAA1024 were blotted using anti-p38 MAPK and 
anti-phospho-p38 MAPK antibodies (Figure 8). The results showed that 
KIAA/PAE cells in serum had lower phosphorylated p38 levels while having 
similar total p38 MAPK levels compared to the other groups.  
KIAA interacts with NOTCH2 
The IP experiment showed a dark band that was present in KIAA1024 but not in 
empty vector (Figure 9A). This section of the gel was cut and analyzed using 
Mass Spectrometry and Scaffold (Figure 9B). The analysis would go on to reveal 
that this dark band was NOTCH2. This interaction between NOTCH2 and KIAA 
was further demonstrated by co-ip experiments (Figure 10A and 10B). As shown 
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in Figure 10B, the bands for KIAA/PAE are noticeably darker than those of 
EV/PAE even though NOTCH2 levels were similar in both. 
 
 
 
Figure 7: KIAA1024 does not affect phosphorylation of p44/42 MAPK in PAE 
cells. Empty vector PAE cells (EV) and KIAA1024 PAE cells (KIAA) in both 
serum and serum starved conditions were probed for p44/42 MAPK and 
phosphorylated p44/42. KIAA1024 expression as well as a protein loading 
control are also included. 
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Figure 8: KIAA1024 inhibits phosphorylation of p38 MAPK in PAE cells in 
serum. Empty vector PAE cells (EV) and KIAA1024 PAE cells (KIAA) in both 
serum and serum starved conditions were probed for p38 MAPK and 
phosphorylated p38. KIAA1024 expression as well as a protein loading control 
are also included. 
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Figure 9: KIAA interacts with NOTCH2 as shown through IP and Mass 
Spectometry. (A) shows the gel for the IP experiment running PAE KIAA1024 
and PAE empty vector. The arrow points to a dark band found in the KIAA1024 
lane that did not exist in the empty vector lane. This band was removed and 
analyzed through Mass Spectrometry (B) The Mass Spectra of a peptide of 
Human NOTCH2 is shown. This dark band was found to be NOTCH2. 
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Figure 10: KIAA1024 interacts with NOTCH2 through co-IP. (A) Whole cell 
lysates derived from PAE empty vector cells (EV/PAE) and overexpressing 
KIAA1024 (KIAA/PAE) were blotted for NOTCH2. KIAA1024 and protein 
loading control is included (B) Result of co-immunoprecipitation of KIAA1024 of 
EV/PAE and KIAA/cells and then blotted for NOTCH2. KIAA expression as well 
as protein loading control are also shown. 
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DISCUSSION 
 
In this study, we identified KIAA1024 as a cell surface protein that is 
expressed in human organs and tissues, including epithelial and endothelial 
cells.  
 Having established expression of KIAA1024 in endothelial cells, we 
sought to examine a possible functional role of KIAA1024 in angiogenesis. One 
major aspect of angiogenesis is the formation of capillary tubes of endothelial 
cells, which involves a coordinated regulation of endothelial cell migration, 
proliferation and differentiation. The data presented in this study demonstrates 
that over-expression of KIAA1024 in PAE cells significantly inhibited capillary 
tube formation of PAE cells. After 24 hours, KIAA/PAE cells formed only minor, 
discrete capillary tubes on the matrigel coated plates. 
 Considering that capillary tube formation of endothelial cells requires a 
coordinated cell migration, we decided to examine the potential role of 
KIAA1024 in cell migration. The data presented in this study demonstrates that 
KIAA1024 promotes cell migration as demonstrated by Boyden Chamber 
migration and wounding assays. 
	32 
 Endothelial cell proliferation and survival are critical for appropriate 
formation of blood vessels. Therefore, we examined the role of KIAA1024 in 
endothelial cell survival. The results showed that KIAA1024 promotes 
endothelial cell survival as demonstrated by MTT assay. To begin dissecting 
molecular signaling of KIAA1024 in endothelial cells, we examined several key 
signaling pathways including mitogen-activated protein kinases, p44/42 MAPK 
and p38 MAPK. MAPKs are regulated by extracellular stimuli such as stress 
signals, growth factors and cytokines and convert them into intracellular 
responses (Roux and Blenis, 2004). The three families of MAPKs in mammals are 
ERKs, JNKs and p38/SAPKs (Morrison, 2012). The MAPK p38 is of particular 
interest since it plays a critical role in angiogenesis by regulating endothelial cell 
survival and migration (Issbrücker et al., 2003). Also, p38 has been shown to play 
a role in cellular senescence, which is a state of growth arrest in normal cells 
(Iwasa et al., 2003). Cellular senescence could be one possible explanation to the 
data shown in the MTT assay (Figure 5B) where the PAE cells overexpressing 
KIAA1024 neither proliferated nor died after 6 days in starvation. Our analysis 
revealed that over-expression of KIAA1024 in PAE cells inhibited 
phosphorylation of p38, whereas it had no measurable effect on the 
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phosphorylation of p44/42 MAPK. The data suggests that KIAA1024 by 
suppressing p38 activity may contribute to cellular responses in endothelial cells. 
Furthermore, KIAA1024 overexpression in PAE cells profoundly affected 
the actin stress fiber formation. Actin stress fiber formation is a critical step in cell 
migration and capillary tube formation (Huang et al., 2002), indicating that 
KIAA1024 expression in PAE cells provokes diverse biological responses that 
affect endothelial cell migration, tube formation, survival and actin stress fiber 
formation.  
Finally, we have identified NOTCH2 as a putative KIAA1024 interacting 
receptor. We used Mass Spectrometry analysis to identify NOTCH2 as a putative 
KIAA1024 interacting receptor. Further, co-immunoprecipitation experiments 
confirmed KIAA1024 binding with NOTCH2. The Notch receptor is a single-pass 
transmembrane receptor that interacts with membrane-bound ligands of the 
Jagged family (JAG1, JAG2) and the Delta-like family (DLL1, DLL3 and DLL4) 
(Kofler et al., 2011). In mammals, there are four different notch receptors: 
NOTCH1, NOTCH2, NOTCH3, and NOTCH4 (Kofler et al., 2011). Notch 
signaling has been shown to provide a critical part in angiogenesis, as it 
promotes the difference between the growing stalk cell and the leading tip 
endothelial cell (Kofler et al., 2011). Once Notch is activated by ligand binding, it 
	34 
is cleaved outside the cell adjacent to the plasma membrane by ADAM (a 
disintegrin and metalloproteinase) proteases (Kofler et al., 2011). This is followed 
by another proteolytic cleavage of the intracellular domain of Notch by gamma-
secretase (Brou et al., 2000). This cleaved domain moves to the nucleus where it 
interacts with DNA-binding protein complex CSL (CBF1/Su(H)/Lag-1) and 
results in gene activation and transcription (Brou et al., 2000).  Improper 
signaling through these receptors has been linked to many diseases, particularly 
cancer (Wu et al., 2010). This has made the Notch pathway a good candidate for 
new drug targets. While gamma secretase inhibitors (GSIs) exist in clinics, they 
cannot differentiate between the Notch receptors (Wu et al., 2010). When both 
NOTCH1 and NOTCH2 were inhibited, it caused intestinal toxicity in mice (van 
Es et al., 2005). However, when there was inhibition of just one of the receptors, 
the intestinal toxicity was reduced or avoided (Wu et al., 2010). NOTCH2 has 
been linked to various cancers such as colon and brain cancers (Koch et al., 2007; 
Leong et al., 2005). Therefore, targeting specifically for the NOTCH2 receptor 
could be useful as an effective treatment of cancer.  
Further studies should continue exploring KIAA1024’s interaction with 
potential other receptors such as NOTCH2. Studies should also explore whether 
KIAA1024 acts as a ligand for NOTCH2 or if KIAA1024 and NOTCH2 on the 
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same cell interact. Knockdown studies of KIAA1024 would also be useful in 
order to see whether cells without KIAA1024 have an opposite effect of those 
found in this study with cells overexpressing KIAA1024. KIAA1024’s role in 
angiogenic diseases, such as cancer, should be studied in order to find out 
whether or not inhibiting pathways could lead to an effective form of treatment.  
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